0001648315-15-000002.txt : 20150826 0001648315-15-000002.hdr.sgml : 20150826 20150826134542 ACCESSION NUMBER: 0001648315-15-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150826 DATE AS OF CHANGE: 20150826 EFFECTIVENESS DATE: 20150826 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HLS Therapeutics Inc. CENTRAL INDEX KEY: 0001648315 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-246478 FILM NUMBER: 151075480 BUSINESS ADDRESS: STREET 1: 17474 HUMBER STATION ROAD CITY: CALEDON STATE: A6 ZIP: L7E 0Z2 BUSINESS PHONE: 416-624-6568 MAIL ADDRESS: STREET 1: 17474 HUMBER STATION ROAD CITY: CALEDON STATE: A6 ZIP: L7E 0Z2 D 1 primary_doc.xml X0707 D LIVE 0001648315 HLS Therapeutics Inc. 17474 HUMBER STATION ROAD CALEDON A6 ONTARIO, CANADA L7E 0Z2 416-624-6568 BRITISH COLUMBIA, CANADA None None Corporation true 2014 Gregory D Gubitz c/o HLS Therapeutics Inc. 17474 Humber Station Road Caledon A6 ONTARIO, CANADA L7E 0Z2 Executive Officer Director Promoter Bill Wells c/o HLS Therapeutics Inc. 17474 Humber Station Road Caledon A6 ONTARIO, CANADA L7E 0Z2 Director Gilbert Godin c/o HLS Therapeutics Inc. 17474 Humber Station Road Caledon A6 ONTARIO, CANADA L7E 0Z2 Executive Officer Director Joseph MacLean c/o HLS Therapeutics Inc. 17474 Humber Station Road Caledon A6 ONTARIO, CANADA L7E 0Z2 Executive Officer Director Chris Fibiger c/o HLS Therapeutics Inc. 17474 Humber Station Road Caledon A6 ONTARIO, CANADA L7E 0Z2 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2015-08-11 false true true true false 2780110 GMP Securities, LLC 41025 None None 530 Fifth Avenue, 15th Floor New York NY NEW YORK 10036 NY NEW YORK false 30000000 30000000 0 false 4 1800000 0 In addition to the advisory fees disclosed above, advisory warrants to purchase 180,000 common shares at an exercise price of US$10.00 per common share through August 11, 2017. 0 false HLS Therapeutics Inc. /s/ Gregory D. Gubitz Gregory D. Gubitz CEO 2015-08-26